Marked Reduction in 30-day Mortality among Elderly Patients with Community-Acquired Pneumonia

作者: Gregory W. Ruhnke , Marcelo Coca-Perraillon , Barrett T. Kitch , David M. Cutler

DOI: 10.1016/J.AMJMED.2010.08.019

关键词:

摘要: Abstract Background Community-acquired pneumonia is the most common infectious cause of death in US. Over last 2 decades, patient characteristics and clinical care have changed. To understand impact these changes, we quantified incidence mortality trends among elderly adults. Methods We used Medicare claims to identify episodes pneumonia, based on a validated combination diagnosis codes. Comorbidities were ascertained using codes located 1-year look back. Trends site compared. The association between year episode 30-day was then evaluated by logistic regression, with adjustment for age, sex, comorbidities. Results identified 2,654,955 cases from 1987-2005. During this period, proportion treated as inpatients decreased, aged ≥80 years increased, frequency many comorbidities rose. Adjusted increased 3096 per 100,000 population 1999, some decrease thereafter. Age/sex-adjusted decreased 13.5% 9.7%, relative reduction 28.1%. Compared 1987, risk through 2005 (adjusted odds ratio, 0.46; 95% confidence interval, 0.44-0.47). This result robust restriction comorbid diagnoses assessing results' sensitivity coding. Conclusions These findings show marked over time community-acquired patients. hypothesize that pneumococcal influenza vaccination rates well wider use guideline-concordant antibiotics explain large portion trend. © 2011 Elsevier Inc. All rights reserved.

参考文章(41)
William J. Hueston, Maria A. Schiaffino, Antibiotic Choice And Patient Outcomes In Community-Acquired Pneumonia Journal of The American Board of Family Practice. ,vol. 7, pp. 95- 99 ,(1994) , 10.3122/JABFM.7.2.95
Vineet Chopra, Scott A. Flanders, Does Statin Use Improve Pneumonia Outcomes? Chest. ,vol. 136, pp. 1381- 1388 ,(2009) , 10.1378/CHEST.09-0941
Thomas P Meehan, Scott R Weingarten, Eric S Holmboe, Deepak Mathur, Yun Wang, Marcia K Petrillo, George S Tu, Jonathan M Fine, A statewide initiative to improve the care of hospitalized pneumonia patients: the Connecticut Pneumonia Pathway Project The American Journal of Medicine. ,vol. 111, pp. 203- 210 ,(2001) , 10.1016/S0002-9343(01)00803-8
Christopher R. Frei, Marcos I. Restrepo, Eric M. Mortensen, David S. Burgess, Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. The American Journal of Medicine. ,vol. 119, pp. 865- 871 ,(2006) , 10.1016/J.AMJMED.2006.02.014
D. Viasus, C. Garcia-Vidal, F. Gudiol, J. Carratalà, Statins for community-acquired pneumonia: current state of the science. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 29, pp. 143- 152 ,(2010) , 10.1007/S10096-009-0835-0
Mark L. Metersky, Janet P. Tate, Michael J. Fine, Marcia K. Petrillo, Thomas P. Meehan, Temporal trends in outcomes of older patients with pneumonia. JAMA Internal Medicine. ,vol. 160, pp. 3385- 3391 ,(2000) , 10.1001/ARCHINTE.160.22.3385
JohnT. Macfarlane, TREATMENT OF LOWER RESPIRATORY INFECTIONS The Lancet. ,vol. 330, pp. 1446- 1449 ,(1987) , 10.1016/S0140-6736(87)91140-8
Michael S. Niederman, John B. Bass, G. Douglas Campbell, Alan M. Fein, Ronald F. Grossman, Lionel A. Mandell, Thomas J. Marrie, George A. Sarosi, Antonio Torres, Victor L. Yu, Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial Therapy The American review of respiratory disease. ,vol. 148, pp. 1418- 1426 ,(1993) , 10.1164/AJRCCM/148.5.1418
Thomas P Meehan, Michael J Fine, Harlan M Krumholz, Jeanne D Scinto, Deron H Galusha, Joyce T Mockalis, Georgina F Weber, Marcia K Petrillo, Peter M Houck, Jonathan M Fine, Quality of Care, Process, and Outcomes in Elderly Patients With Pneumonia JAMA: The Journal of the American Medical Association. ,vol. 278, pp. 2080- 2084 ,(1997) , 10.1001/JAMA.1997.03550230056037
Julio A. Ramírez, Processes of care for community-acquired pneumonia Infectious Disease Clinics of North America. ,vol. 18, pp. 843- 859 ,(2004) , 10.1016/J.IDC.2004.08.004